From a metabolic standpoint, the activation of PPARs is widely employed in the treatment of diabetes and dyslipidemia, owing to its efficacy in enhancing insulin sensitivity and modulating lipid distribution [39]. This evidence concerns the gene INS and diabetes mellitus.